WHO ICTRP trial

To compare thinner blood(with 40% Red Blood Cell) versus thicker blood(with 60%…

CTRI/2024/04/065454 · Clinical Trials Registry India (CTRI) · Not Recruiting

Key facts

Trial ID CTRI/2024/04/065454
Public title To compare thinner blood(with 40% Red Blood Cell) versus thicker blood(with 60% Red Blood Cell) during exchange transfusion in Rh negative pregnancy
Scientific title Comparison of reconstituted blood with 40 ± 5% versus 60 ± 5% hematocrit for double volume exchange transfusion in neonates with hemolytic disease of the newborn: a randomized controlled trial - NIL
Primary sponsor All India Institute of Medical Sciences, New Delhi
Registry Clinical Trials Registry India (CTRI)
Recruitment status Not Recruiting
Study type Interventional
Phase Phase 2/ Phase 3
Countries India
Conditions Health Condition 1: P550- Rh isoimmunization of newborn
Interventions Intervention1: Double volume exchange transfusion with 40 ± 5% hematocrit: All neonates with Rh isoimmunization will be screened for enrolment. The parents will be approached for consent after applying the inclusion and exclusion criteria…
Registration date Sep 4, 2024
Target size 50
Secondary IDs NIL
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations